Bicara Therapeutics

Court lawsuit legal litigation
Biotech

Biocon accused of IP theft to create cancer biotech Bicara

Bicara and its former parent company have been hit with accusations of intellectual property theft.
Fraiser Kansteiner Oct 24, 2024 11:04am
Graphic image of the letters IPO in white in front of a yellow background

Zenas, MBX, Bicara head to Nasdaq in hot day for biotech IPOs

Sep 13, 2024 5:25am
IPO initial public offering Wall Street

Zenas, Bicara set out to raise $180M-plus in separate IPOs

Sep 6, 2024 8:18am
IPO initial public offering markets raise financing

Bicara, Zenas seek IPOs to push late-phase assets toward market

Aug 23, 2024 5:07am
dollars money ocean dollar bill

Bicara raises second $100M+ round of 2023, closing new series C

Dec 12, 2023 6:30am
parachute chutes

Pfizer exec out the door—Chutes & Ladders

Jul 28, 2023 9:30am